Summit Healthcare REIT, Inc financial data

Location
Laguna Hills, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 186% % -88%
Return On Equity 0.41% % -100%
Return On Assets 0.14% % -99%
Operating Margin 158% % 229%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23,027,978 shares 0%
Common Stock, Shares, Outstanding 23,027,978 shares 0%
Entity Public Float $0 USD
Common Stock, Value, Issued $23,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 23,027,978 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 23,027,978 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $12,965,000 USD -27%
General and Administrative Expense $4,318,000 USD -12%
Operating Income (Loss) $21,064,000 USD 110%
Net Income (Loss) Attributable to Parent $100,000 USD -100%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $23,946,000 USD -1%
Operating Lease, Right-of-Use Asset $100,000 USD -83%
Intangible Assets, Net (Excluding Goodwill) $1,188,000 USD -91%
Assets $69,335,000 USD -66%
Liabilities $45,521,000 USD -74%
Retained Earnings (Accumulated Deficit) $91,872,000 USD 0.11%
Stockholders' Equity Attributable to Parent $23,661,000 USD -3.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $23,814,000 USD -3.6%
Liabilities and Equity $69,335,000 USD -66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $173,000 USD 75%
Net Cash Provided by (Used in) Financing Activities $327,000 USD 58%
Net Cash Provided by (Used in) Investing Activities $336,000 USD 89%
Common Stock, Shares Authorized 290,000,000 shares 0%
Common Stock, Shares, Issued 23,027,978 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $836,000 USD 82%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $26,795,000 USD -1%
Interest Paid, Excluding Capitalized Interest, Operating Activities $389,000 USD -87%
Deferred Tax Assets, Valuation Allowance $1,400,000 USD 27%
Operating Lease, Liability $128,000 USD -83%
Depreciation $1,500,000 USD -57%
Lessee, Operating Lease, Liability, to be Paid $129,000 USD -84%
Lessee, Operating Lease, Liability, to be Paid, Year Two $56,000 USD -74%
Lessee, Operating Lease, Liability, to be Paid, Year One $73,000 USD -66%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,000 USD -99%
Lessee, Operating Lease, Liability, to be Paid, Year Three $231,000 USD 3.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $99,000 USD -57%
Operating Lease, Payments $54,000 USD 1.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $200,000 USD -80%
Depreciation, Depletion and Amortization $358,000 USD -76%
Interest Expense $1,878,000 USD -49%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%